Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Generation Bio ( (GBIO) ) has shared an announcement.
On June 4, 2025, Generation Bio Co. conducted its annual meeting of stockholders, where key proposals were voted upon. The meeting resulted in the election of Ron Cooper, Anthony Quinn, and Jason Rhodes as Class II directors, ratification of Ernst & Young LLP as the independent auditor, approval of executive compensation, and authorization of a reverse stock split amendment.
The most recent analyst rating on (GBIO) stock is a Buy with a $5.00 price target. To see the full list of analyst forecasts on Generation Bio stock, see the GBIO Stock Forecast page.
Spark’s Take on GBIO Stock
According to Spark, TipRanks’ AI Analyst, GBIO is a Neutral.
Generation Bio’s overall stock score is driven by significant financial challenges, particularly in profitability and financial stability. Technical analysis suggests a lack of strong momentum, while valuation metrics highlight concerns over negative earnings. The absence of earnings call insights and corporate events means these factors do not influence the score.
To see Spark’s full report on GBIO stock, click here.
More about Generation Bio
Average Trading Volume: 498,221
Technical Sentiment Signal: Sell
Current Market Cap: $26.73M
Find detailed analytics on GBIO stock on TipRanks’ Stock Analysis page.